
IMDA eNews 092623
The latest news affecting you and your customers…
from the Independent Medical Specialty Dealers Association
Innovative devices can help address inequities, says FDA
AARC award-winners
Breakthrough designation for spinal fusion device
Don Sizemore, Bill Carmouche to participate in AdvaMed Conference
Non-physicians deliver one-fourth of U.S. health visits
Esophageal device gets De Novo designation
The FDA has granted Chicago-based Attune Medical De Novo marketing authorization for its esophageal heat transfer device (ensoETM). Attune Medical’s single-use silicone tube is inserted into the esophagus and acts as a thermal regulating device that cools the esophageal wall via a connected heat exchange unit. The closed-loop system gives surgeons the ability to proactively control temperature management. The De Novo designation provides a marketing pathway to classify novel medical devices for which general controls alone, or general and special controls, provide reasonable assurance of safety and effectiveness for the intended use, but for which there is no legally marketed predicate device
Keep your company protected against scammers
The FBI receives 300,000 email scam filings each year. Business scams are a large part of them. Is your company protected? Are your employees aware of the risk they can put your company in when receiving and sending emails? At the upcoming 2024 IMDA/HIRA Annual Conference and Manufacturers Forum, March 4-6, in Orlando, Florida, IMDA Executive Director Don Sizemore will show you how a common scam can cost you money. He should know, as his business was a victim of one. At the conference, learn how such scams work, how to spot them, and what to do once you are in the scam situation. Click here to register for the 2024 IMDA/HIRA Annual Conference and Manufacturers Forum